Acute Respiratory Distress Syndrome (ARDS) Clinical Trials

Find Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Near You

Real-Time Algorithm-Driven Ventilation Feedback to Improve Lung-Protective Ventilation in Patients With ARDS (REALVENT-study)

Status: Recruiting
Location: See location...
Intervention Type: Device, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The REALVENT trial is designed to evaluate whether a real-time, algorithm-driven ventilation feedback strategy can improve lung-protective ventilation (LPV) achievement rates in critically ill patients receiving invasive mechanical ventilation. This multicentre randomised controlled trial will compare real-time respiratory waveform monitoring with automated feedback against standard ICU care. The primary endpoint is the LPV achievement rate over the first 72 hours.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Age between 18 and 75 years

• Receiving invasive mechanical ventilation via endotracheal intubation at the time of screening

• Initiation of invasive mechanical ventilation within the past 24 hours

• PaO₂/FiO₂ ≤ 200 mmHg on PEEP ≥ 8 cmH₂O or, if arterial blood gas is unavailable: SpO₂/FiO₂ ≤ 235 with SpO₂ ≤ 97%

• Chest imaging (chest X-ray or CT) showing bilateral pulmonary infiltrates not fully explained by pleural effusions, lobar collapse, or pulmonary nodules

• Respiratory failure not fully explained by cardiac failure or fluid overload

• Expected to require invasive mechanical ventilation for ≥ 72 hours after enrollment

Locations
Other Locations
China
Qujing Central Hospital of Yunnan Province
RECRUITING
Qujing
Contact Information
Primary
Longxiang Su, Doctor
slx77@163.com
+86 15652797257
Time Frame
Start Date: 2025-12-30
Estimated Completion Date: 2027-02-28
Participants
Target number of participants: 208
Treatments
Experimental: REal-time Algorithm-driven Ventilation feedback to improve lung-protective ventilation in critically
Patients in the intervention arm will receive real-time ventilator waveform monitoring through the respiratory dynamics monitoring and feedback RemoteVentilate ViewTM system. The system continuously collects high-frequency waveform data (flow, pressure, volume) directly from the ventilator interface and analyses the following metrics: Tidal volume (VT) indexed to predicted body weight, Driving pressure (ΔP), Plateau pressure (Pplat), and Mechanical power (MP). Patient-ventilator asynchrony (PVA) events will be also collected in the system, including double triggering, ineffective efforts, reverse triggering, and flow starvation, ect
Active_comparator: Standard ICU care
The control group will receive standard ICU care, including routine monitoring of ventilator parameters such as tidal volume, plateau pressure, and oxygenation status. No structured feedback or external ventilation reports will be provided. This reflects the prevailing standard of care in Chinese ICUs and is thus an appropriate comparator for assessing the added value of a real-time respiratory feedback platform.
Sponsors
Collaborators: Chongqing General Hospital, Henan Provincial People's Hospital, Beijing Hepingli Hospital, Binzhou Second People's Hospital, Qujing Central Hospital of Yunnan Province, Beijing No.6 Hospital, Capital Medical University Affiliated Beijing Anzhen Hospital, Nanchong Center, Jinzhou Medical University, Shandong Provincial Hospital
Leads: Peking Union Medical College Hospital

This content was sourced from clinicaltrials.gov